Three classes, not one word
Peptides are not steroids, and they are not SARMs. A peptide is a short chain of amino acids joined by peptide bonds. An anabolic steroid is built on a four-ring cholesterol nucleus and dissolves in fat. SARMs are a third class, synthetic ligands aimed at the androgen receptor. The comparison below and the 1971 Schedule 2 text keep those labels as separate as the chemistry.
Are peptides steroids?
No. A peptide is a short chain of amino acids linked by peptide bonds, and it acts as a cellular signalling messenger. An anabolic steroid is a synthetic, fat-soluble molecule built on a four-ring cholesterol nucleus. The two classes are not interchangeable, whatever a forum post claims.
This is the whole answer to the question in the page name, and it is a chemical answer rather than a slogan. BPC-157, TB-500, GHK-Cu, Epitalon, and MOTS-c are sequences. They are studied as signalling messengers in cellular assays and in published preclinical models. They do not become steroids because someone puts them in the same sentence as a steroid. NCBI Bookshelf is the plain biochemistry shelf for the peptide bond and the steroid nucleus.
The legal split follows the chemical split. Anabolic steroids are named as Class C controlled substances. The research peptides in the catalogue are not those entries. Schedule 2, Part III and the UK legality guide are there when you want the boundary in full.
Peptide hormones, steroid hormones, and SARMs
Peptide signalling and steroid signalling do not share one receptor class. Peptide sequences are studied at cell-surface receptors and at targets inside the cell. Anabolic steroids are studied at androgen receptors after they cross a fatty membrane. SARMs are a third class aimed at that same androgen receptor.
Calling all three hormones in casual speech hides the difference you actually need. A peptide is still amino acids and peptide bonds, usually studied at the cell surface. A steroid is a small fat-soluble molecule built on the four-ring nucleus, studied after it crosses a membrane. SARMs, selective androgen receptor modulators, are synthetic ligands aimed at that androgen receptor. They are not short peptides, and they are not the four-ring steroids named on the 1971 list. Catalogue examples of the peptide side are BPC-157, CJC-1295, Ipamorelin, Kisspeptin-10, and PT-141.
How UK law keeps the three classes apart
Anabolic steroids are named as Class C controlled substances on the 1971 Schedule 2 list. The peptides in this catalogue are not on that list. SARMs are neither peptides nor those steroid entries. A peptide answer does not describe a SARM, and this shop does not sell SARMs.
The criminal-law list names anabolic steroids and certain full-length polypeptide hormones such as somatropin. It does not name the short sequences sold here. That is why the legality guide can say research peptides are lawful to buy for in-vitro work. It cannot say the same sentence about anabolic steroids, because those are the named Class C entries. SARMs need their own reading of the statute. This page will not pretend a peptide answer covers them.
Sport rules are a second column. The WADA Prohibited List puts many peptide hormones and secretagogues in Section S2, and non-approved substances in Section S0. Anabolic steroids sit with the anabolic agents. A tested athlete can be prohibited from something a private laboratory may still purchase. UK Anti-Doping is the British authority for that sport question.
Do peptides affect testosterone signalling?
Some peptide sequences are studied for pulse signalling upstream of growth-hormone or gonadotropin pathways in published models. That is not an anabolic steroid sitting on the androgen receptor. The pathway depends on the sequence, and Amino Peptides sells the vial and the paperwork rather than a finished result.
Kisspeptin-10 is studied at KISS1R, upstream of GnRH, in published models. CJC-1295 without DAC, and Tesamorelin, are studied as growth-hormone-releasing hormone receptor ligands. Ipamorelin is studied as a selective secretagogue at GHS-R1a. Those are pulse and upstream questions. An anabolic steroid question is an androgen-receptor question. The mechanisms are not interchangeable, and the papers are where the model results live.
Nothing on this page is a promise about testosterone in a person. The work is in-vitro and preclinical. Concentration in an assay is not a personal schedule, and this site does not publish one. If you want the vials themselves, use the secretagogue category and the endocrine and melanocortin category.
What are the Big 3 research peptides?
Searchers call BPC-157, TB-500, and GHK-Cu the Big 3. They are grouped because people ask about tissue, actin, and copper-matrix research, not because the three are steroids or SARMs. Each sequence has its own catalogue page, its own cake, and its own batch file.
The nickname is a search habit, and it is a useful one if you know what it actually groups. BPC-157 is the fifteen-amino-acid peptide people pair with cellular-migration and angiogenic readouts in published models. TB-500 is a thymosin beta-4 fragment studied for actin handling. GHK-Cu is the copper-binding tripeptide studied in collagen and matrix assays. The trio is not a chemical class, and it is not a steroid class. You will find them in the tissue and recovery category and the skin and copper category. Purity for each one is covered in the purity and COA guide.
Research peptides, anabolic steroids, and SARMs
| Topic | Research peptides | Anabolic steroids | SARMs |
|---|---|---|---|
| Chemical structure | Short amino-acid chain, peptide bonds | Four-ring cholesterol steroid nucleus, fat-soluble | Synthetic androgen-receptor ligands, not peptides |
| Presence in biology | Many signalling motifs already occur as peptides | The steroid nucleus is the cholesterol pattern | Designed ligands, not a native peptide family |
| Receptor mechanism | Cell-surface receptors and intracellular peptide targets | Androgen receptor after the molecule crosses a membrane | Aimed at the androgen receptor |
| Endocrine and testosterone profile | Upstream pulse questions in published models, sequence by sequence | Studied for androgen-receptor occupation | Androgen-receptor models, not peptide signalling |
| Half-life and clearance | Sequence-specific. Published models often use a short window | Fat-soluble, so published models discuss a longer window | Ligand-specific. Published models set the window |
| UK legal classification | Not listed on the 1971 Schedule 2 | Named as Class C controlled substances | Not those steroid entries. This catalogue does not sell them |
| Primary research focus | Cellular signalling, matrix, mitochondrial, and receptor assays | Androgen-receptor models | Selective androgen-receptor models |
Frequently Asked Questions
Primary sources
These are the primary documents. Statute short titles are given here so the citation matches the instrument a reader opens.